Piper Sandler Reiterates Overweight Rating on Arrowhead Pharma (ARWR)
Go back to Piper Sandler Reiterates Overweight Rating on Arrowhead Pharma (ARWR)| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 85.11 -1.23 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.34 | 52 Week High | $8.22 | |||
| Open | $84.22 | 52 Week Low | $3.07 | |||
| Day High | $86.96 | P/E | N/A | |||
| Day Low | $83.54 | EPS | $-1.30 | |||
| Volume | 1,568,098 | |||||
